04/22/2024
2:39 PM | Bioxytran (Filer)
| Form 10-Q/A | |
04/19/2024
3:50 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:26 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:23 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
1:46 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
03/27/2024
4:56 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:58 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:48 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:17 PM | Bioxytran (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/16/2024
9:00 AM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
9:03 AM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
9:06 AM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
9:09 AM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
8:53 AM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
11/02/2023
8:02 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
8:05 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
8:07 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
5:34 AM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
10:36 AM | Bioxytran (Filer)
| Form 424B4 | |
10/01/2023
11:15 PM | Bioxytran (Filer)
| Form EFFECT | |
09/26/2023
4:04 PM | Bioxytran (Filer)
| Form S-1/A | |
09/21/2023
9:53 AM | Bioxytran (Filer)
| Form DEL AM | |
09/19/2023
12:05 PM | Bioxytran (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/15/2023
5:21 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:06 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:09 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:11 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:15 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
1:45 PM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:15 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
11:15 PM | Bioxytran (Filer)
| Form EFFECT | |
08/14/2023
7:07 PM | Bioxytran (Filer)
| Form 424B4 | |
08/08/2023
7:36 PM | Bioxytran (Filer)
| Form S-1/A | |
08/02/2023
8:32 PM | Bioxytran (Filer)
| Form S-1/A | |
07/31/2023
1:07 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2023
6:19 PM | Bioxytran (Filer)
| Form S-1/A | |
07/07/2023
8:23 AM | Bioxytran (Filer)
| Form S-1/A | |
06/16/2023
6:01 AM | Bioxytran (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
They say it’s ‘unstoppable’ – How I made 43,509% (Ad) Not long ago I joined Phil Ash for a private one-on-one interview.
And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015…
Without a single loss. Click here now for the full story. |
06/12/2023
5:11 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
4:11 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
5:08 AM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
8:55 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
7:33 AM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
7:35 AM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
7:38 AM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
7:26 AM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
